Loading…

EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice

The epithelial-mesenchymal transition (EMT) is an embryonic transdifferentiation process consisting of conversion of polarized epithelial cells to motile mesenchymal ones. EMT-inducing transcription factors are aberrantly expressed in multiple tumor types and are known to favor the metastatic dissem...

Full description

Saved in:
Bibliographic Details
Published in:PLoS genetics 2012-05, Vol.8 (5), p.e1002723
Main Authors: Morel, Anne-Pierre, Hinkal, George W, Thomas, Clémence, Fauvet, Frédérique, Courtois-Cox, Stéphanie, Wierinckx, Anne, Devouassoux-Shisheboran, Mojgan, Treilleux, Isabelle, Tissier, Agnès, Gras, Baptiste, Pourchet, Julie, Puisieux, Isabelle, Browne, Gareth J, Spicer, Douglas B, Lachuer, Joël, Ansieau, Stéphane, Puisieux, Alain
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c826t-3e63e724d1a290664fa91448e4b7d186559a43c2a16011db2e23c32bc13df5923
cites cdi_FETCH-LOGICAL-c826t-3e63e724d1a290664fa91448e4b7d186559a43c2a16011db2e23c32bc13df5923
container_end_page
container_issue 5
container_start_page e1002723
container_title PLoS genetics
container_volume 8
creator Morel, Anne-Pierre
Hinkal, George W
Thomas, Clémence
Fauvet, Frédérique
Courtois-Cox, Stéphanie
Wierinckx, Anne
Devouassoux-Shisheboran, Mojgan
Treilleux, Isabelle
Tissier, Agnès
Gras, Baptiste
Pourchet, Julie
Puisieux, Isabelle
Browne, Gareth J
Spicer, Douglas B
Lachuer, Joël
Ansieau, Stéphane
Puisieux, Alain
description The epithelial-mesenchymal transition (EMT) is an embryonic transdifferentiation process consisting of conversion of polarized epithelial cells to motile mesenchymal ones. EMT-inducing transcription factors are aberrantly expressed in multiple tumor types and are known to favor the metastatic dissemination process. Supporting oncogenic activity within primary lesions, the TWIST and ZEB proteins can prevent cells from undergoing oncogene-induced senescence and apoptosis by abolishing both p53- and RB-dependent pathways. Here we show that they also downregulate PP2A phosphatase activity and efficiently cooperate with an oncogenic version of H-RAS in malignant transformation of human mammary epithelial cells. Thus, by down-regulating crucial tumor suppressor functions, EMT inducers make cells particularly prone to malignant conversion. Importantly, by analyzing transformed cells generated in vitro and by characterizing novel transgenic mouse models, we further demonstrate that cooperation between an EMT inducer and an active form of RAS is sufficient to trigger transformation of mammary epithelial cells into malignant cells exhibiting all the characteristic features of claudin-low tumors, including low expression of tight and adherens junction genes, EMT traits, and stem cell-like characteristics. Claudin-low tumors are believed to be the most primitive breast malignancies, having arisen through transformation of an early epithelial precursor with inherent stemness properties and metaplastic features. Challenging this prevailing view, we propose that these aggressive tumors arise from cells committed to luminal differentiation, through a process driven by EMT inducers and combining malignant transformation and transdifferentiation.
doi_str_mv 10.1371/journal.pgen.1002723
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1313570904</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A294370117</galeid><doaj_id>oai_doaj_org_article_cea742889eda4b7e8c8e6148940ce073</doaj_id><sourcerecordid>A294370117</sourcerecordid><originalsourceid>FETCH-LOGICAL-c826t-3e63e724d1a290664fa91448e4b7d186559a43c2a16011db2e23c32bc13df5923</originalsourceid><addsrcrecordid>eNqVk99qFDEUxgdRbK2-geiAIPRi1_ybycyNUEq1C6sFrd6GbHJmN0sm2SaZ1voUPrJZd1t2RUHJxYST3_m-nJM5RfEcozGmHL9Z-iE4acerObgxRohwQh8Uh7iq6IgzxB7u7A-KJzEuEaJV0_LHxQEhdcVqXh0WP84-XJbG6UFBiKWSSdrb71D20pq5ky6VKUgXOx96mYx3pe_yWd_LcFvCyqQFWCNtqcDaWEqnSx3MNZRp6H0w-WIQTSyTv5FBZ3UrB23cyPqbDRGz88Ygo0aVvVHwtHjUSRvh2fZ7VHx5d3Z5ej6aXryfnJ5MR6ohdRpRqClwwjSWpEV1zTrZYsYaYDOucVNXVSsZVUTiGmGsZwQIVZTMFKa6q1pCj4qXG92V9VFsmxkFpphWHLWIZWKyIbSXS7EKZl218NKIXwEf5kKGZJQFoUByRpqmBS3zBaBRDdSYNS1DChCnWevt1m2Y9aAVuFy23RPdP3FmIeb-WlBatW2Ds8DxRmDxW9r5yVSsYwhxTBhn12v21dYs-KsBYvpLeVtqLnMFxnU-G6veRCVOSMsoz33jmRr_gcpLQ34t76AzOb6XcLyXkJkE39JcDjGKyedP_8F-_Hf24us--3qHXYC0aRG9HdZ_cNwH2QZUwccYoLtvLUZiPWV3nRPrKRPbKctpL3Zf8z7pbqzoTxw1Isk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1313570904</pqid></control><display><type>article</type><title>EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Morel, Anne-Pierre ; Hinkal, George W ; Thomas, Clémence ; Fauvet, Frédérique ; Courtois-Cox, Stéphanie ; Wierinckx, Anne ; Devouassoux-Shisheboran, Mojgan ; Treilleux, Isabelle ; Tissier, Agnès ; Gras, Baptiste ; Pourchet, Julie ; Puisieux, Isabelle ; Browne, Gareth J ; Spicer, Douglas B ; Lachuer, Joël ; Ansieau, Stéphane ; Puisieux, Alain</creator><contributor>Horwitz, Marshall S.</contributor><creatorcontrib>Morel, Anne-Pierre ; Hinkal, George W ; Thomas, Clémence ; Fauvet, Frédérique ; Courtois-Cox, Stéphanie ; Wierinckx, Anne ; Devouassoux-Shisheboran, Mojgan ; Treilleux, Isabelle ; Tissier, Agnès ; Gras, Baptiste ; Pourchet, Julie ; Puisieux, Isabelle ; Browne, Gareth J ; Spicer, Douglas B ; Lachuer, Joël ; Ansieau, Stéphane ; Puisieux, Alain ; Horwitz, Marshall S.</creatorcontrib><description>The epithelial-mesenchymal transition (EMT) is an embryonic transdifferentiation process consisting of conversion of polarized epithelial cells to motile mesenchymal ones. EMT-inducing transcription factors are aberrantly expressed in multiple tumor types and are known to favor the metastatic dissemination process. Supporting oncogenic activity within primary lesions, the TWIST and ZEB proteins can prevent cells from undergoing oncogene-induced senescence and apoptosis by abolishing both p53- and RB-dependent pathways. Here we show that they also downregulate PP2A phosphatase activity and efficiently cooperate with an oncogenic version of H-RAS in malignant transformation of human mammary epithelial cells. Thus, by down-regulating crucial tumor suppressor functions, EMT inducers make cells particularly prone to malignant conversion. Importantly, by analyzing transformed cells generated in vitro and by characterizing novel transgenic mouse models, we further demonstrate that cooperation between an EMT inducer and an active form of RAS is sufficient to trigger transformation of mammary epithelial cells into malignant cells exhibiting all the characteristic features of claudin-low tumors, including low expression of tight and adherens junction genes, EMT traits, and stem cell-like characteristics. Claudin-low tumors are believed to be the most primitive breast malignancies, having arisen through transformation of an early epithelial precursor with inherent stemness properties and metaplastic features. Challenging this prevailing view, we propose that these aggressive tumors arise from cells committed to luminal differentiation, through a process driven by EMT inducers and combining malignant transformation and transdifferentiation.</description><identifier>ISSN: 1553-7404</identifier><identifier>ISSN: 1553-7390</identifier><identifier>EISSN: 1553-7404</identifier><identifier>DOI: 10.1371/journal.pgen.1002723</identifier><identifier>PMID: 22654675</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Apoptosis ; Biology ; Breast cancer ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Cancer ; Cell Differentiation ; Cell Line ; Cell Transformation, Neoplastic - genetics ; Cell Transformation, Neoplastic - metabolism ; Claudins - genetics ; Claudins - metabolism ; Colonies &amp; territories ; Development and progression ; Epithelial Cells - cytology ; Epithelial Cells - metabolism ; Epithelial-Mesenchymal Transition - genetics ; Experiments ; Female ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genes, ras ; Genetic aspects ; Homeodomain Proteins - genetics ; Homeodomain Proteins - metabolism ; Humans ; Life Sciences ; Mammary Glands, Animal - cytology ; Mammary Glands, Animal - metabolism ; Mammary Glands, Human - cytology ; Mammary Glands, Human - metabolism ; Medicine ; Mice ; Mice, Transgenic ; Physiological aspects ; Protein Phosphatase 2 - antagonists &amp; inhibitors ; Protein Phosphatase 2 - metabolism ; Proteins ; Retinoblastoma Protein - metabolism ; Risk factors ; Rodents ; Telomerase - metabolism ; Transcription factors ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Tumor Suppressor Protein p53 - metabolism ; Tumors ; Twist-Related Protein 1 - genetics ; Twist-Related Protein 1 - metabolism ; Zinc Finger E-box-Binding Homeobox 1</subject><ispartof>PLoS genetics, 2012-05, Vol.8 (5), p.e1002723</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>2012 Morel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Morel A-P, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, et al. (2012) EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice. PLoS Genet 8(5): e1002723. doi:10.1371/journal.pgen.1002723</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Morel et al. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c826t-3e63e724d1a290664fa91448e4b7d186559a43c2a16011db2e23c32bc13df5923</citedby><cites>FETCH-LOGICAL-c826t-3e63e724d1a290664fa91448e4b7d186559a43c2a16011db2e23c32bc13df5923</cites><orcidid>0000-0002-5676-8719 ; 0000-0001-9794-9615 ; 0000-0003-0989-2108 ; 0000-0002-9938-3798</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1313570904/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1313570904?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22654675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00712474$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Horwitz, Marshall S.</contributor><creatorcontrib>Morel, Anne-Pierre</creatorcontrib><creatorcontrib>Hinkal, George W</creatorcontrib><creatorcontrib>Thomas, Clémence</creatorcontrib><creatorcontrib>Fauvet, Frédérique</creatorcontrib><creatorcontrib>Courtois-Cox, Stéphanie</creatorcontrib><creatorcontrib>Wierinckx, Anne</creatorcontrib><creatorcontrib>Devouassoux-Shisheboran, Mojgan</creatorcontrib><creatorcontrib>Treilleux, Isabelle</creatorcontrib><creatorcontrib>Tissier, Agnès</creatorcontrib><creatorcontrib>Gras, Baptiste</creatorcontrib><creatorcontrib>Pourchet, Julie</creatorcontrib><creatorcontrib>Puisieux, Isabelle</creatorcontrib><creatorcontrib>Browne, Gareth J</creatorcontrib><creatorcontrib>Spicer, Douglas B</creatorcontrib><creatorcontrib>Lachuer, Joël</creatorcontrib><creatorcontrib>Ansieau, Stéphane</creatorcontrib><creatorcontrib>Puisieux, Alain</creatorcontrib><title>EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice</title><title>PLoS genetics</title><addtitle>PLoS Genet</addtitle><description>The epithelial-mesenchymal transition (EMT) is an embryonic transdifferentiation process consisting of conversion of polarized epithelial cells to motile mesenchymal ones. EMT-inducing transcription factors are aberrantly expressed in multiple tumor types and are known to favor the metastatic dissemination process. Supporting oncogenic activity within primary lesions, the TWIST and ZEB proteins can prevent cells from undergoing oncogene-induced senescence and apoptosis by abolishing both p53- and RB-dependent pathways. Here we show that they also downregulate PP2A phosphatase activity and efficiently cooperate with an oncogenic version of H-RAS in malignant transformation of human mammary epithelial cells. Thus, by down-regulating crucial tumor suppressor functions, EMT inducers make cells particularly prone to malignant conversion. Importantly, by analyzing transformed cells generated in vitro and by characterizing novel transgenic mouse models, we further demonstrate that cooperation between an EMT inducer and an active form of RAS is sufficient to trigger transformation of mammary epithelial cells into malignant cells exhibiting all the characteristic features of claudin-low tumors, including low expression of tight and adherens junction genes, EMT traits, and stem cell-like characteristics. Claudin-low tumors are believed to be the most primitive breast malignancies, having arisen through transformation of an early epithelial precursor with inherent stemness properties and metaplastic features. Challenging this prevailing view, we propose that these aggressive tumors arise from cells committed to luminal differentiation, through a process driven by EMT inducers and combining malignant transformation and transdifferentiation.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Biology</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Cancer</subject><subject>Cell Differentiation</subject><subject>Cell Line</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Cell Transformation, Neoplastic - metabolism</subject><subject>Claudins - genetics</subject><subject>Claudins - metabolism</subject><subject>Colonies &amp; territories</subject><subject>Development and progression</subject><subject>Epithelial Cells - cytology</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial-Mesenchymal Transition - genetics</subject><subject>Experiments</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genes, ras</subject><subject>Genetic aspects</subject><subject>Homeodomain Proteins - genetics</subject><subject>Homeodomain Proteins - metabolism</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Mammary Glands, Animal - cytology</subject><subject>Mammary Glands, Animal - metabolism</subject><subject>Mammary Glands, Human - cytology</subject><subject>Mammary Glands, Human - metabolism</subject><subject>Medicine</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Physiological aspects</subject><subject>Protein Phosphatase 2 - antagonists &amp; inhibitors</subject><subject>Protein Phosphatase 2 - metabolism</subject><subject>Proteins</subject><subject>Retinoblastoma Protein - metabolism</subject><subject>Risk factors</subject><subject>Rodents</subject><subject>Telomerase - metabolism</subject><subject>Transcription factors</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Tumors</subject><subject>Twist-Related Protein 1 - genetics</subject><subject>Twist-Related Protein 1 - metabolism</subject><subject>Zinc Finger E-box-Binding Homeobox 1</subject><issn>1553-7404</issn><issn>1553-7390</issn><issn>1553-7404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqVk99qFDEUxgdRbK2-geiAIPRi1_ybycyNUEq1C6sFrd6GbHJmN0sm2SaZ1voUPrJZd1t2RUHJxYST3_m-nJM5RfEcozGmHL9Z-iE4acerObgxRohwQh8Uh7iq6IgzxB7u7A-KJzEuEaJV0_LHxQEhdcVqXh0WP84-XJbG6UFBiKWSSdrb71D20pq5ky6VKUgXOx96mYx3pe_yWd_LcFvCyqQFWCNtqcDaWEqnSx3MNZRp6H0w-WIQTSyTv5FBZ3UrB23cyPqbDRGz88Ygo0aVvVHwtHjUSRvh2fZ7VHx5d3Z5ej6aXryfnJ5MR6ohdRpRqClwwjSWpEV1zTrZYsYaYDOucVNXVSsZVUTiGmGsZwQIVZTMFKa6q1pCj4qXG92V9VFsmxkFpphWHLWIZWKyIbSXS7EKZl218NKIXwEf5kKGZJQFoUByRpqmBS3zBaBRDdSYNS1DChCnWevt1m2Y9aAVuFy23RPdP3FmIeb-WlBatW2Ds8DxRmDxW9r5yVSsYwhxTBhn12v21dYs-KsBYvpLeVtqLnMFxnU-G6veRCVOSMsoz33jmRr_gcpLQ34t76AzOb6XcLyXkJkE39JcDjGKyedP_8F-_Hf24us--3qHXYC0aRG9HdZ_cNwH2QZUwccYoLtvLUZiPWV3nRPrKRPbKctpL3Zf8z7pbqzoTxw1Isk</recordid><startdate>20120501</startdate><enddate>20120501</enddate><creator>Morel, Anne-Pierre</creator><creator>Hinkal, George W</creator><creator>Thomas, Clémence</creator><creator>Fauvet, Frédérique</creator><creator>Courtois-Cox, Stéphanie</creator><creator>Wierinckx, Anne</creator><creator>Devouassoux-Shisheboran, Mojgan</creator><creator>Treilleux, Isabelle</creator><creator>Tissier, Agnès</creator><creator>Gras, Baptiste</creator><creator>Pourchet, Julie</creator><creator>Puisieux, Isabelle</creator><creator>Browne, Gareth J</creator><creator>Spicer, Douglas B</creator><creator>Lachuer, Joël</creator><creator>Ansieau, Stéphane</creator><creator>Puisieux, Alain</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7SS</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>1XC</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5676-8719</orcidid><orcidid>https://orcid.org/0000-0001-9794-9615</orcidid><orcidid>https://orcid.org/0000-0003-0989-2108</orcidid><orcidid>https://orcid.org/0000-0002-9938-3798</orcidid></search><sort><creationdate>20120501</creationdate><title>EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice</title><author>Morel, Anne-Pierre ; Hinkal, George W ; Thomas, Clémence ; Fauvet, Frédérique ; Courtois-Cox, Stéphanie ; Wierinckx, Anne ; Devouassoux-Shisheboran, Mojgan ; Treilleux, Isabelle ; Tissier, Agnès ; Gras, Baptiste ; Pourchet, Julie ; Puisieux, Isabelle ; Browne, Gareth J ; Spicer, Douglas B ; Lachuer, Joël ; Ansieau, Stéphane ; Puisieux, Alain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c826t-3e63e724d1a290664fa91448e4b7d186559a43c2a16011db2e23c32bc13df5923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Biology</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Cancer</topic><topic>Cell Differentiation</topic><topic>Cell Line</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Cell Transformation, Neoplastic - metabolism</topic><topic>Claudins - genetics</topic><topic>Claudins - metabolism</topic><topic>Colonies &amp; territories</topic><topic>Development and progression</topic><topic>Epithelial Cells - cytology</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial-Mesenchymal Transition - genetics</topic><topic>Experiments</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genes, ras</topic><topic>Genetic aspects</topic><topic>Homeodomain Proteins - genetics</topic><topic>Homeodomain Proteins - metabolism</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Mammary Glands, Animal - cytology</topic><topic>Mammary Glands, Animal - metabolism</topic><topic>Mammary Glands, Human - cytology</topic><topic>Mammary Glands, Human - metabolism</topic><topic>Medicine</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Physiological aspects</topic><topic>Protein Phosphatase 2 - antagonists &amp; inhibitors</topic><topic>Protein Phosphatase 2 - metabolism</topic><topic>Proteins</topic><topic>Retinoblastoma Protein - metabolism</topic><topic>Risk factors</topic><topic>Rodents</topic><topic>Telomerase - metabolism</topic><topic>Transcription factors</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Tumors</topic><topic>Twist-Related Protein 1 - genetics</topic><topic>Twist-Related Protein 1 - metabolism</topic><topic>Zinc Finger E-box-Binding Homeobox 1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morel, Anne-Pierre</creatorcontrib><creatorcontrib>Hinkal, George W</creatorcontrib><creatorcontrib>Thomas, Clémence</creatorcontrib><creatorcontrib>Fauvet, Frédérique</creatorcontrib><creatorcontrib>Courtois-Cox, Stéphanie</creatorcontrib><creatorcontrib>Wierinckx, Anne</creatorcontrib><creatorcontrib>Devouassoux-Shisheboran, Mojgan</creatorcontrib><creatorcontrib>Treilleux, Isabelle</creatorcontrib><creatorcontrib>Tissier, Agnès</creatorcontrib><creatorcontrib>Gras, Baptiste</creatorcontrib><creatorcontrib>Pourchet, Julie</creatorcontrib><creatorcontrib>Puisieux, Isabelle</creatorcontrib><creatorcontrib>Browne, Gareth J</creatorcontrib><creatorcontrib>Spicer, Douglas B</creatorcontrib><creatorcontrib>Lachuer, Joël</creatorcontrib><creatorcontrib>Ansieau, Stéphane</creatorcontrib><creatorcontrib>Puisieux, Alain</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale_Opposing Viewpoints In Context</collection><collection>Gale In Context: Canada</collection><collection>Gale in Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PLoS genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morel, Anne-Pierre</au><au>Hinkal, George W</au><au>Thomas, Clémence</au><au>Fauvet, Frédérique</au><au>Courtois-Cox, Stéphanie</au><au>Wierinckx, Anne</au><au>Devouassoux-Shisheboran, Mojgan</au><au>Treilleux, Isabelle</au><au>Tissier, Agnès</au><au>Gras, Baptiste</au><au>Pourchet, Julie</au><au>Puisieux, Isabelle</au><au>Browne, Gareth J</au><au>Spicer, Douglas B</au><au>Lachuer, Joël</au><au>Ansieau, Stéphane</au><au>Puisieux, Alain</au><au>Horwitz, Marshall S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice</atitle><jtitle>PLoS genetics</jtitle><addtitle>PLoS Genet</addtitle><date>2012-05-01</date><risdate>2012</risdate><volume>8</volume><issue>5</issue><spage>e1002723</spage><pages>e1002723-</pages><issn>1553-7404</issn><issn>1553-7390</issn><eissn>1553-7404</eissn><abstract>The epithelial-mesenchymal transition (EMT) is an embryonic transdifferentiation process consisting of conversion of polarized epithelial cells to motile mesenchymal ones. EMT-inducing transcription factors are aberrantly expressed in multiple tumor types and are known to favor the metastatic dissemination process. Supporting oncogenic activity within primary lesions, the TWIST and ZEB proteins can prevent cells from undergoing oncogene-induced senescence and apoptosis by abolishing both p53- and RB-dependent pathways. Here we show that they also downregulate PP2A phosphatase activity and efficiently cooperate with an oncogenic version of H-RAS in malignant transformation of human mammary epithelial cells. Thus, by down-regulating crucial tumor suppressor functions, EMT inducers make cells particularly prone to malignant conversion. Importantly, by analyzing transformed cells generated in vitro and by characterizing novel transgenic mouse models, we further demonstrate that cooperation between an EMT inducer and an active form of RAS is sufficient to trigger transformation of mammary epithelial cells into malignant cells exhibiting all the characteristic features of claudin-low tumors, including low expression of tight and adherens junction genes, EMT traits, and stem cell-like characteristics. Claudin-low tumors are believed to be the most primitive breast malignancies, having arisen through transformation of an early epithelial precursor with inherent stemness properties and metaplastic features. Challenging this prevailing view, we propose that these aggressive tumors arise from cells committed to luminal differentiation, through a process driven by EMT inducers and combining malignant transformation and transdifferentiation.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>22654675</pmid><doi>10.1371/journal.pgen.1002723</doi><orcidid>https://orcid.org/0000-0002-5676-8719</orcidid><orcidid>https://orcid.org/0000-0001-9794-9615</orcidid><orcidid>https://orcid.org/0000-0003-0989-2108</orcidid><orcidid>https://orcid.org/0000-0002-9938-3798</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1553-7404
ispartof PLoS genetics, 2012-05, Vol.8 (5), p.e1002723
issn 1553-7404
1553-7390
1553-7404
language eng
recordid cdi_plos_journals_1313570904
source PubMed Central Free; Publicly Available Content Database
subjects Animals
Apoptosis
Biology
Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Cancer
Cell Differentiation
Cell Line
Cell Transformation, Neoplastic - genetics
Cell Transformation, Neoplastic - metabolism
Claudins - genetics
Claudins - metabolism
Colonies & territories
Development and progression
Epithelial Cells - cytology
Epithelial Cells - metabolism
Epithelial-Mesenchymal Transition - genetics
Experiments
Female
Gene expression
Gene Expression Regulation, Neoplastic
Genes, ras
Genetic aspects
Homeodomain Proteins - genetics
Homeodomain Proteins - metabolism
Humans
Life Sciences
Mammary Glands, Animal - cytology
Mammary Glands, Animal - metabolism
Mammary Glands, Human - cytology
Mammary Glands, Human - metabolism
Medicine
Mice
Mice, Transgenic
Physiological aspects
Protein Phosphatase 2 - antagonists & inhibitors
Protein Phosphatase 2 - metabolism
Proteins
Retinoblastoma Protein - metabolism
Risk factors
Rodents
Telomerase - metabolism
Transcription factors
Transcription Factors - genetics
Transcription Factors - metabolism
Tumor Suppressor Protein p53 - metabolism
Tumors
Twist-Related Protein 1 - genetics
Twist-Related Protein 1 - metabolism
Zinc Finger E-box-Binding Homeobox 1
title EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T02%3A22%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EMT%20inducers%20catalyze%20malignant%20transformation%20of%20mammary%20epithelial%20cells%20and%20drive%20tumorigenesis%20towards%20claudin-low%20tumors%20in%20transgenic%20mice&rft.jtitle=PLoS%20genetics&rft.au=Morel,%20Anne-Pierre&rft.date=2012-05-01&rft.volume=8&rft.issue=5&rft.spage=e1002723&rft.pages=e1002723-&rft.issn=1553-7404&rft.eissn=1553-7404&rft_id=info:doi/10.1371/journal.pgen.1002723&rft_dat=%3Cgale_plos_%3EA294370117%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c826t-3e63e724d1a290664fa91448e4b7d186559a43c2a16011db2e23c32bc13df5923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1313570904&rft_id=info:pmid/22654675&rft_galeid=A294370117&rfr_iscdi=true